Turbidimetric Determination of Prothrombin Time by Clotting in a Centrifugal
We used 60 plasma samples from patients with various diseases or being treated with oral anticoagulant and 16 normal plasma samples. Prothrombin times were calculated by a computer connected to the analyzer, a reading being made at either a certain per cent increase in total absorbance or a fixed absorbance increase. Both correlated well with the manual method (r = 0.98-0.99).
The reading points best fitting the manually obtained data were estimated by minimizing the residual sum of squares in regression analyses performed at various absorbance increases. The per cent reading was better in this respect.
Normotest Automated could be nearly perfectly related to the manual method, whereas Thrombotest showed a (negligibly) small deviation.
Reproducibility was good within run (CV 3.2%) as well as between batch of the reagents, as assessed from variation in INR (CV 4.9%).
We 
Materials
and Methods
Instrumentation.
We used a Cobas Bio centrifugal analyzer linked to an IBM Personal Computer through a RS 232 C Interface, and a "Cobpoll handshake"
program (NYCOMED AS, Oslo, Norway).
Reagents.
Two combined thromboplastin reagents were tested:
"Thrombotest" contains bovine-brain thromboplastin; "Normotest Automated" contains rabbit-brain thromboplastin.
Both are from NYCOMED AS. From Figure  l#{192} it can be seen that the clotting time PT corresponding to a certain LA can be computed by use of the equation
Procedures
Method 2: computing the time to reach a certain percentage of the total absorbance change ("ratio method"). This method may be less dependent on total absorbance change, but may depend on variations in kinetics of clot formation. From Figure  1 , it can be seen that the absorbance change LA corresponding to a certain relative absorbance increase can be computed from the equation
and, by using equation 1 and 2 together, the clotting time can be calculated.
The behavior of these two methods for determination of prothrombin time formed part of our investigation and is described in the Results section. 2. Regression with equational and 2 used in determining %LA.
The optimum LA and %LA were estimated by minimizing the residual sum of squares. 
Plasma

Results
Absorption
Spectra
So we could visualize the absorbance change during the clotting reaction, thromboplastin reagent and plasma were mixed and the reaction was followed over the spectral range 300-600 nm in a Hewlett Packard 8451A Diode Array Spectrophotometer. Figure  2 shows the absorption spectra arising in the course of the reaction with use of Thrombotest, and the inset to Figure  2 shows the corresponding differential spectra obtained by subtracting from each spectrum the spectrum measured before the reaction started. 
Reproducibility
A set of plasmas with various coagulation activities was chosen for the study of reproducibility. Table 3 shows the results. The CV was in the range 0.5-3.2%
for Thrombotest and 0.7-2.9%
for Normotest Automated when the ratio method was used. Repetition of this series of readings showed a similar CV for each plasma. Thus this variation seems to be a property of each plasma, and also apparently is independent of the total absorbance increase.
We measured the same set of plasmas, using five different batches of Thrombotest and four batches of Normotest Automated.
The batches were different with respect to clotting times and sensitivity and covered the normal variation in available batches of the products. Each batch was tested in a separate run. To make the results comparable, we converted all the prothrombin times to INR, using the characteristic normal prothrombin time and descriptive factors "ISI" (Thrombotest) and "a" and "d" (Normotest  Automated) for each batch. The results are shown in In either case, the time spent will be more or less the same based on the need for preparation of plasmas, loading the machine, and analysis time. The main difference will be a more economical assay that obviates the cost of chromogenic substrates. By careful instrument construction the present method also opens the way for automated centrifugal analyzers, which may measure whole-blood samples.
